Second-line treatment for renal cell cancer

被引：4

作者：

Di Lorenzo, G. ^{[1
]}

De Placido, S. ^{[1
]}

Buonerba, C. ^{[1
]}

机构：

[1] Univ Federico II, Dipartimento Endocrinol Oncol Clin & Mol, Naples, Italy

来源：

BRITISH JOURNAL OF CANCER | 2012年 / 106卷 / 04期

关键词：

TARGETED THERAPIES; 1ST-LINE TREATMENT; PHASE-3; TRIAL; CARCINOMA; SUNITINIB; BEVACIZUMAB; EVEROLIMUS; INHIBITORS; SORAFENIB;

D O I：

10.1038/bjc.2011.611

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：617 / 618

页数：2

共 14 条

[1]

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma [J].

Benedict, Agnes ;

Figlin, Robert A. ;

Sandstrom, Per ;

Harmenberg, Ulrika ;

Ullen, Anders ;

Charbonneau, Claudie ;

Sandin, Rickard ;

Remak, Edit ;

Hariharan, Subramanian ;

Negrier, Sylvie .

BJU INTERNATIONAL, 2011, 108 (05) :665-672

[2]

Bracarda S, 2011, BR J CANC

[3]

Sequence Therapy in Patients with Metastatic Renal Cell Carcinoma: Comparison of Common Targeted Treatment Options Following Failure of Receptor Tyrosine Kinase Inhibitors [J].

Busch, Jonas ;

Seidel, Christoph ;

Kempkensteffen, Carsten ;

Johannsen, Manfred ;

Wolff, Ingmar ;

Hinz, Stefan ;

Magheli, Ahmed ;

Miller, Kurt ;

Gruenwald, Viktor ;

Weikert, Steffen .

EUROPEAN UROLOGY, 2011, 60 (06) :1163-1170

[4]

Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness [J].

Coon, J. S. Thompson ;

Liu, Z. ;

Hoyle, M. ;

Rogers, G. ;

Green, C. ;

Moxham, T. ;

Welch, K. ;

Stein, K. .

BRITISH JOURNAL OF CANCER, 2009, 101 (02) :238-243

[5]

Toxicities of Targeted Therapy and Their Management in Kidney Cancer [J].

Di Lorenzo, Giuseppe ;

Porta, Camillo ;

Bellmunt, Joaquim ;

Sternberg, Cora ;

Kirkali, Ziya ;

Staehler, Michael ;

Joniau, Steven ;

Montorsi, Francesco ;

Buonerba, Carlo .

EUROPEAN UROLOGY, 2011, 59 (04) :526-540

[6]

Third-Line Sorafenib After Sequential Therapy With Sunitinib and mTOR Inhibitors in Metastatic Renal Cell Carcinoma [J].

Di Lorenzo, Giuseppe ;

Buonerba, Carlo ;

Federico, Piera ;

Rescigno, Pasquale ;

Milella, Michele ;

Ortega, Cinzia ;

Aieta, Michele ;

D'Aniello, Carmine ;

Longo, Nicola ;

Felici, Alessandra ;

Ruggeri, Enzo Maria ;

Palmieri, Giovannella ;

Imbimbo, Ciro ;

Aglietta, Massimo ;

De Placido, Sabino ;

Mirone, Vincenzo .

EUROPEAN UROLOGY, 2010, 58 (06) :906-911

[7]

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer [J].

Di Lorenzo, Giuseppe ;

Carteni, Giacomo ;

Autorino, Riccardo ;

Bruni, Gianni ;

Tudini, Marianna ;

Rizzo, Mimma ;

Aieta, Michele ;

Gonnella, Antonio ;

Rescigno, Pasquale ;

Perdona, Sisto ;

Giannarini, Gianluca ;

Pignata, Sandro ;

Longo, Nicola ;

Palmieri, Giovannella ;

Imbimbo, Ciro ;

De Laurentiis, Michele ;

Mirone, Vincenzo ;

Ficorella, Corrado ;

De Placido, Sabino .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4469-4474

[8]

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies [J].

Gore, M. E. ;

Larkin, J. M. G. .

BRITISH JOURNAL OF CANCER, 2011, 104 (03) :399-406

[9]

Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies [J].

Gruenwald, V. ;

Seidel, C. ;

Fenner, M. ;

Ganser, A. ;

Busch, J. ;

Weikert, S. .

BRITISH JOURNAL OF CANCER, 2011, 105 (11) :1635-1639

[10]

Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors [J].

Motzer, Robert J. ;

Escudier, Bernard ;

Oudard, Stephane ;

Hutson, Thomas E. ;

Porta, Camillo ;

Bracarda, Sergio ;

Grunwald, Viktor ;

Thompson, John A. ;

Figlin, Robert A. ;

Hollaender, Norbert ;

Kay, Andrea ;

Ravaud, Alain .

CANCER, 2010, 116 (18) :4256-4265

← 1 2 →